Guna-awareness Solution/ Drops
NDC Package 17089-350-18
Package Information
Guna-awareness (betaine - bufo bufo cutaneous gland - calcium carbonate - chromic sulfate - cicuta virosa root - copper - folic acid - gold - cobalamin - iron - lachesis muta venom - melatonin - molybdenum - neurotrophin-3 - neurotrophin-4 - oxytocin - silicon dioxide - sus scrofa frontal lobe - sus scrofa temporal lobe - thyrotropin alfa - ubidecarenone - vanadium - zinc - brain-derived neurotrophic factor human -) solution/ dropses is take 15 minutes before mealsAdults and children 12 years and older 20 drops in a little water, 2 times per dayChildren between 12 years and 6 years of age 10 drops in a little water, 2 times per dayChildren under 6 years 5 drops in a glass of water, 2 times per day. This formulation utilizes a solution/ drops delivery system. Marketed by Guna Spa, this product is identified by NDC 17089-350.
Identification & Billing
Clinical Specifications
- BETAINE 3 [hp_X]/30mL
- BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN 4 [hp_C]/30mL
- BUFO BUFO CUTANEOUS GLAND 12 [hp_X]/30mL
- CALCIUM CARBONATE 3 [hp_X]/30mL
- CHROMIC SULFATE 3 [hp_X]/30mL
- CICUTA VIROSA ROOT 12 [hp_X]/30mL
- COBALAMIN 3 [hp_X]/30mL
- COPPER 12 [hp_X]/30mL
- FOLIC ACID 3 [hp_X]/30mL
- GOLD 12 [hp_X]/30mL
- IRON 3 [hp_X]/30mL
- LACHESIS MUTA VENOM 12 [hp_X]/30mL
- MELATONIN 4 [hp_C]/30mL
- MOLYBDENUM 3 [hp_X]/30mL
- NEUROTROPHIN-3 4 [hp_C]/30mL
- NEUROTROPHIN-4 4 [hp_C]/30mL
- OXYTOCIN 6 [hp_X]/30mL
- SILICON DIOXIDE 12 [hp_X]/30mL
- SUS SCROFA FRONTAL LOBE 6 [hp_X]/30mL
- SUS SCROFA TEMPORAL LOBE 6 [hp_X]/30mL
- THYROTROPIN ALFA 3 [hp_X]/30mL
- UBIDECARENONE 3 [hp_X]/30mL
- VANADIUM 6 [hp_X]/30mL
- ZINC 3 [hp_X]/30mL
- Allergens - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Cations, Divalent - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased Uterine Smooth Muscle Contraction or Tone - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Methylating Activity - [MoA] (Mechanism of Action)
- Methylating Agent - [EPC] (Established Pharmacologic Class)
- Oxytocic - [EPC] (Established Pharmacologic Class)
- Oxytocin - [CS]
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Thyroid Stimulating Hormone - [EPC] (Established Pharmacologic Class)
- Thyrotropin - [CS]
Regulatory & Marketing
Hierarchy Structure
- 17089 - Guna Spa
- 17089-350 - Guna-awareness
- 17089-350-18 - 1 BOTTLE, DROPPER in 1 BOX / 30 mL in 1 BOTTLE, DROPPER
- 17089-350 - Guna-awareness
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17089-350-18 identifies a specific commercial package of 1 bottle, dropper in 1 box / 30 ml in 1 bottle, dropper of Guna-awareness, a human over the counter drug labeled by Guna Spa. This solution/ drops is formulated for oral use and contains betaine; brain-derived neurotrophic factor human; bufo bufo cutaneous gland; calcium carbonate; chromic sulfate; cicuta virosa root; cobalamin; copper; folic acid; gold; iron; lachesis muta venom; melatonin; molybdenum; neurotrophin-3; neurotrophin-4; oxytocin; silicon dioxide; sus scrofa frontal lobe; sus scrofa temporal lobe; thyrotropin alfa; ubidecarenone; vanadium; zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guna Spa on April 16, 2008. The current certification is valid through December 31, 2027.
How is this Guna Spa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17089035018. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.